Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness

Introduction. The incidence of Acute Myeloid Leukemia (AML) increases progressively with age and its treatment is challenging. This prospective case control study was undertaken to compare the safety, efficacy, and cost-effectiveness of decitabine with those of cytarabine in older patients with newl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Linu A., Aparna, S., Lakshmaiah, K. C., Lokanatha, D., Babu, Govind, Babu, Suresh, Appachu, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649104/
https://www.ncbi.nlm.nih.gov/pubmed/26617639
http://dx.doi.org/10.1155/2015/167029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649104/
https://www.ncbi.nlm.nih.gov/pubmed/26617639
http://dx.doi.org/10.1155/2015/167029

Ejemplares similares